Jarod Rutledge is the Director of Biotechnology and Life Sciences at Starbloom Capital – a stage-agnostic investment firm focused on frontier biotechnology and AI – and the Director of Longevity Research at the Amaranth Foundation – a philanthropic organization for moonshot neuroscience, AI, and longevity research. A recovering academic, Jarod’s research has leveraged AI, multi-omics, and advanced imaging data to build more predictive tools for drug development. His work has been published in Nature, Cell, Science, and featured in global news outlets including The New York Times, The Wall Street Journal, and Time Magazine. He is a co-founder of companies in CNS drug development, molecular diagnostics, and computer vision technology. At Starbloom, his investment portfolio includes multiple companies developing more predictive models for drug discovery. Jarod received a Ph.D. in Genetics from Stanford University and completed postdoctoral training in AI at Stanford and EMBL Heidelberg.